Japan’s stable supply system for pharmaceuticals： its inspiration for enhancing the supply assurance capability of drugs in shortage in China

WANG Linning; GU Lingna; YU Jie; LU Yun

doi:10.6039/j.issn.1001-0408.2024.10.01

您当前的位置：

首页 >

文章列表页 >

Japan’s stable supply system for pharmaceuticals： its inspiration for enhancing the supply assurance capability of drugs in shortage in China

更新时间：2025-09-25

- Japan’s stable supply system for pharmaceuticals： its inspiration for enhancing the supply assurance capability of drugs in shortage in China
- ZHONGGUO YAOFANG Vol. 35, Issue 10, Pages: 1157-1162(2024)
- 作者机构：
  
  中国药科大学国际医药商学院，南京　211198
- 作者简介：
- 基金信息：
- DOI：10.6039/j.issn.1001-0408.2024.10.01
  CLC： R95
- Received：18 September 2023，
  
  Revised：2024-03-13，
  
  Accepted：14 March 2024，
  
  Published：30 May 2024
- 稿件说明：
移动端阅览
王琳宁,顾灵娜,虞杰,等.日本药品稳定供应制度对提升我国短缺药供应保障能力的政策启示[J].中国药房,2024,35(10):1157-1162.

WANG Linning,GU Lingna,YU Jie,et al.Japan’s stable supply system for pharmaceuticals： its inspiration for enhancing the supply assurance capability of drugs in shortage in China[J].ZHONGGUO YAOFANG,2024,35(10):1157-1162.
王琳宁,顾灵娜,虞杰,等.日本药品稳定供应制度对提升我国短缺药供应保障能力的政策启示[J].中国药房,2024,35(10):1157-1162. DOI： 10.6039/j.issn.1001-0408.2024.10.01.

WANG Linning,GU Lingna,YU Jie,et al.Japan’s stable supply system for pharmaceuticals： its inspiration for enhancing the supply assurance capability of drugs in shortage in China[J].ZHONGGUO YAOFANG,2024,35(10):1157-1162. DOI： 10.6039/j.issn.1001-0408.2024.10.01.

摘要

目的

为提升我国短缺药供应保障能力提供思路。

方法

通过梳理日本药品稳定供应制度的顶层设计思路，详细介绍日本现行的药品稳定供应政策内容，并结合我国短缺药供应保障的现存问题提出政策建议。

结果与结论

日本为了保障药品稳定供应，制定了贯穿“事前预防措施、早期风险监测、发生供应问题时的应对机制”三阶段的政策框架体系。事前预防措施包括建立药品稳定保供清单分级分类制度、掌握易断供药品的制造程序和流程、建立药品持续供应和停产报告制度；早期风险监测包括建立企业供应风险自查评估制度、公开企业供应保障信息、制定价格保护与激励措施；发生供应问题时的应对机制包括建立企业增产和协调供货机制、建立原料药变更快速审评审批制度、建立紧急强制调货供应制度。建议我国从细化短缺药遴选标准、加强信息公开流转、优化价格管理手段、明确问题反馈与处理4个方面，精细化短缺药激励与监管政策，兼顾短缺药“保供应”和“强监管”。

Abstract

OBJECTIVE

To provide insights for enhancing the supply assurance capability of drugs in shortage in China.

METHODS

By sorting out top-level design ideas for Japan’s stable supply system for pharmaceuticals， this study elaborates on its current policies for stabilizing drug supply. Policy suggestions were proposed for existing challenges in the supply of drugs in shortage in China.

RESULTS &

CONCLUSIONS

To stabilize drug supply， Japan formulated a systematic 3-tier policy framework that ran through pre-prevention， early risk monitoring， and response mechanisms for supply problems. Pre-prevention measures included establishing a graded classification system for stable supply lists， strengthening government control over the drug production process， and implementing a continuous supply system and cessation reporting system for post-market drugs. Early risk monitoring included self-assessing risks in enterprises， disclosing information concerning supply assurance of enterprises， and providing enterprises with price protection and incentives measures. Response mechanisms for supply problems included establishing the mechanism of increasing production and coordinated supply in enterprises， opening fast-track review and approval channels for changes in raw materials， and establishing emergency systems of transferring drugs to supply. To balance supply assurance and strong regulation of drugs in shortage through refining the incentive and regulatory policies for them， it is recommended to refine the criteria for selecting drugs in shortage， strengthen the circulation of information， optimize price management methods， and clarify problem feedback and solving.

关键词

Keywords

references

BADE C ， OLSACHER A ， BOEHME P ， et al . Reasons for supply side driven drug shortages： a mixed-methods study on first-level，higher-level，and root causes from the perspective of marketing authorization holders [J ] . Res Social Adm Pharm ， 2023 ， 19 （ 8 ）： 1218 - 1227 .

李大双，颜建周，白铭钰，等 . 国家组织药品集中采购供应问题及对策研究 [J ] . 卫生经济研究， 2022 ， 39 （ 6 ）： 12 - 16 .

LI D S ， YAN J Z ， BAI M Y ， et al . Research on the supply problems and countermeasures of national centralized drug procurement [J ] . Health Econ Res ， 2022 ， 39 （ 6 ）： 12 - 16 .

李勇，温庆辉，郭述金，等 . 我国儿童用药供给短缺现状、成因及对策分析 [J ] . 中国药物评价， 2023 ， 40 （ 2 ）： 126 - 129 .

LI Y ， WEN Q H ， GUO S J ， et al . Analysis on the current situation，causes and countermeasures of the supply shor-tage of pediatric drug in China [J ] . Chin J Drug Eval ， 2023 ， 40 （ 2 ）： 126 - 129 .

胡泽利 . 短缺药品价格和供应监测处置现状及对策研究 [J ] . 中国医疗保险， 2023 （ 10 ）： 12 - 21 .

HU Z L . Research on the current situations and solutions to the monitoring and administration of under-supply drugs price and supply [J ] . China Health Insur ， 2023 （ 10 ）： 12 - 21 .

厚生労働省 . 医薬品の安定確保を図るための取組：現状と今後の取組 [EB/OL ] .（ 2021-03-26 ）[ 2024-02-02 ] . https：//www.mhlw.go.jp/content/10807000/000758433.pdf https://www.mhlw.go.jp/content/10807000/000758433.pdf .

Ministry of Health ， Labour and Welfare . Efforts to secure stable supply of pharmaceutical products：current status and future efforts [EB/OL ] .（ 2021-03-26 ）[ 2024-02-02 ] . https：//www.mhlw.go.jp/content/10807000/000758433.pdf https://www.mhlw.go.jp/content/10807000/000758433.pdf .

厚生労働省 . 安定確保医薬品の選定及びカテゴリ設定等の考え方について [EB/OL ] .（ 2021-02-18 ）[ 2024-02-02 ] . https：//public-comment.e-gov.go.jp/servlet/PcmFileDownload?seqNo=0000214931 https://public-comment.e-gov.go.jp/servlet/PcmFileDownload?seqNo=0000214931 .

Ministry of Health ， Labour and Welfare . Approaches to the selection of stable secure medicines and category setting，etc .[EB/OL ] .（ 2021-02-18 ）[ 2024-02-02 ] . https：//public-comment.e-gov.go.jp/servlet/PcmFileDownload?seqNo=0000214931 https://public-comment.e-gov.go.jp/servlet/PcmFileDownload?seqNo=0000214931 .

厚生労働省 . 安定確保医薬品及びカテゴリ設定 [EB/OL ] .（ 2021-05-27 ）[ 2024-02-02 ] . https：//www.mhlw.go.jp/content/10807000/000785498.pdf https://www.mhlw.go.jp/content/10807000/000785498.pdf .

Ministry of Health ， Labour and Welfare . Stable and secure drugs and category setting [EB/OL ] .（ 2021-05-27 ）[ 2024-02-02 ] . https：//www.mhlw.go.jp/content/10807000/00078-5498.pdf https://www.mhlw.go.jp/content/10807000/00078-5498.pdf .

厚生労働省 . サプライチェーンマッピング [EB/OL ] .（ 2022-03-25 ）[ 2024-02-02 ] . https：//www.mhlw.go.jp/content/10807000/000918543.pdf https://www.mhlw.go.jp/content/10807000/000918543.pdf .

Ministry of Health ， Labour and Welfare . Supply chain mapping [EB/OL ] .（ 2022-03-25 ）[ 2024-02-02 ] . https：//www.mhlw.go.jp/content/10807000/000918543.pdf https://www.mhlw.go.jp/content/10807000/000918543.pdf .

厚生労働省 . 薬価基準収載医薬品の供給停止について：改訂 [EB/OL ] .（ 2020-10-19 ）[ 2024-02-02 ] . https：//www.toku-seiyakukyo.jp/data/drug_news/2020/1_16030677119-368.pdf https://www.toku-seiyakukyo.jp/data/drug_news/2020/1_16030677119-368.pdf .

Ministry of Health ， Labour and Welfare . Suspension of supply of drugs listed in the NHI drug price standards： revised [EB/OL ] .（ 2020-10-19 ）[ 2024-02-02 ] . https：//www.toku-seiyakukyo.jp/data/drug_news/2020/1_16030677119-368.pdf https://www.toku-seiyakukyo.jp/data/drug_news/2020/1_16030677119-368.pdf .

厚生労働省 . 医療用医薬品の安定供給に関する自己点検の実施について：依頼 [EB/OL ] .（ 2019-07-05 ）[ 2023-08-31 ] . https：//www.mhlw.go.jp/content/10807000/00061-3170.pdf https://www.mhlw.go.jp/content/10807000/00061-3170.pdf .

Ministry of Health ， Labour and welfare . Implementation of self-inspection on stable supply of ethical drugs：request [EB/OL ] .（ 2019-07-05 ）[ 2023-08-31 ] . https：//www.mhlw.go.jp/content/10807000/000613170.pdf https://www.mhlw.go.jp/content/10807000/000613170.pdf .

厚生労働省 . 医薬品の安定供給について② [EB/OL ] .（ 2023-04-14 ）[ 2024-03-07 ] . https：//www.mhlw.go.jp/content/10807000/001087794.pdf https://www.mhlw.go.jp/content/10807000/001087794.pdf .

Ministry of Health ， Labour and Welfare . Stable supply of pharmaceuticals （ 2 ）[EB/OL ] .（ 2023-04-14 ）[ 2024-03-07 ] . https：//www.mhlw.go.jp/content/10807000/001087794.pdf https://www.mhlw.go.jp/content/10807000/001087794.pdf .

国家卫生健康委 . 国家短缺药品清单管理办法：试行 [EB/OL ] .（ 2020-04-20 ）[ 2024-02-02 ] . https：//www.gov.cn/zhengce/zhengceku/2020-04/24/5505943/files/cfab9e4b70fe414495bca16dbae50df1.pdf https://www.gov.cn/zhengce/zhengceku/2020-04/24/5505943/files/cfab9e4b70fe414495bca16dbae50df1.pdf .

National Health Commission of the People’s Republic of China . Management of the national shortage drug list：trial [EB/OL ] .（ 2020-04-20 ）[ 2024-02-02 ] . https：//www.gov.cn/zhengce/zhengceku/2020-04/24/5505943/files/cfab9e4b70-fe414495bca16dbae50df1.pdf https://www.gov.cn/zhengce/zhengceku/2020-04/24/5505943/files/cfab9e4b70-fe414495bca16dbae50df1.pdf .

王丽娜，李亦蕾，王煜昊，等 . 我国短缺药品的采购方式及优化研究 [J ] . 卫生经济研究， 2024 ， 41 （ 2 ）： 36 - 40 .

WANG L N ， LI Y L ， WANG Y H ， et al . Study on the procurement model and optimization of drug shortage in China [J ] . Health Econ Res ， 2024 ， 41 （ 2 ）： 36 - 40 .

王乾，杨浩宇，贾宇衡，等 . 国家易短缺药品清单纳入品种分析及思考 [J ] . 卫生经济研究， 2023 ， 40 （ 10 ）： 57 - 60 .

WANG Q ， YANG H Y ， JIA Y H ， et al . Analysis and thoughts on the varieties included in national shortage drug list [J ] . Health Econ Res ， 2023 ， 40 （ 10 ）： 57 - 60 .

谭清立，梁诗渝 . 基于政策工具的短缺药供应保障机制的推进与优化研究 [J ] . 中国卫生政策研究， 2021 ， 14 （ 12 ）： 26 - 33 .

TAN Q L ， LIANG S Y . Research on the advancement and optimization of the shortage drug supply guarantee mechanisms based on policy tools [J ] . Chin J Health Policy ， 2021 ， 14 （ 12 ）： 26 - 33 .

邵蓉，孙海顺，张梦 . 英国短缺药品联络人报告制度对我国的启示 [J ] . 卫生经济研究， 2016 （ 12 ）： 22 - 25 .

SHAO R ， SUN H S ， ZHANG M . Enlightenment of contact person reporting system of shortage drugs in Britain to China [J ] . Health Econ Res ， 2016 （ 12 ）： 22 - 25 .

郭志，陈益强 . 短缺药品区域储备协作实践分析与探索 [J ] . 中国处方药， 2022 ， 20 （ 9 ）： 54 - 56 .

GUO Z ， CHEN Y Q . Analysis and exploration on the cooperative practice of regional reserve of drugs in short supply [J ] . J China Prescr Drug ， 2022 ， 20 （ 9 ）： 54 - 56 .

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

No data

Related Author

No data

Related Institution

No data

Address：8th Floor, Sihuan Building, No. 129 Daping Main Street, Yuzhong District, Chongqing, China Postal code：400042
Technical support is provided by Beijing Founder Electronics co., LTD 渝ICP备15012710号公网安备50010302001817
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰